Therametics Technology 

Therametics technology is based on a proprietary cell and molecular biology screening strategy (Therascreen) which has identified several novel bioactive compounds that suppress a variety of inflammatory responses in cultured skin cells (keratinocytes and fibroblasts), and immune cells (monocytes and T- lymphocytes).  To learn more about Therascreen click on the link below:

Therascreen Advantage

Upon identification of a novel bioactive, a formulation is then engineered to deliver precise amounts of the bioactive of interest.  Toxicology and clinical studies are then performed to ensure the safety and efficacy of the engineered formulation.  To learn more about the steps involved in Therametics product engineering click on the link below:

Therametics Product Engineering

Using the Therascreen anti-inflammatory bioactive screening strategy, Therametics scientists have discovered a number of botanically derived compounds that are able to block the production of key players involved in inflammation.  To learn more about the development of our anti-inflammatory technology and our lead anti-inflammatory compound Therosol, click on the link below:

Anti-Inflammatory Technology

Using the Therascreen anti-aging bioactive screening strategy, Therametics scientists have discovered the revolutionary anti-aging Therosol IV complex, which is able to increase production of collagen, elastin and hyaluronic acid, as well as reduce the loss of collagen upon sun exposure.  To learn more about the development of our anti-aging technology and the Therosol IV complex, click on the link below:

Anti-Aging Technology